Additionally, it has been shown that the DNMT inhibitors 5-azacytidine and RG108 are able to elicit expression changes in Hep3B hepatocellular carcinoma cells within 24 h of dosing [74], thus epigenetic alterations to cytosine methylation can clearly arise quickly. Here, DNMT1 is linked to hepatocellular carcinoma.